Arkadios Wealth Advisors Makes New $613,000 Investment in Relx Plc $RELX

Arkadios Wealth Advisors acquired a new stake in shares of Relx Plc (NYSE:RELX) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 11,288 shares of the technology company’s stock, valued at approximately $613,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Goldman Sachs Group Inc. raised its position in shares of Relx by 4.5% during the first quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company’s stock valued at $205,287,000 after buying an additional 173,976 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock valued at $154,129,000 after buying an additional 234,094 shares during the last quarter. Northern Trust Corp raised its position in shares of Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock valued at $120,686,000 after buying an additional 202,509 shares during the last quarter. Natixis Advisors LLC raised its position in shares of Relx by 0.5% during the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company’s stock valued at $60,919,000 after buying an additional 5,875 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Relx by 103.4% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock valued at $22,400,000 after buying an additional 225,947 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.

Relx Trading Down 0.2%

RELX stock opened at $44.14 on Tuesday. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx Plc has a twelve month low of $43.88 and a twelve month high of $56.33. The firm’s fifty day simple moving average is $46.25 and its two-hundred day simple moving average is $50.40.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on RELX shares. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Barclays reiterated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Relx in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.